Form 4: Hookipa Pharma EVP and CFO, Mary Theresa Coelho, Reports Acquisition of Restricted Stock Units

Mary Theresa Coelho, EVP and CFO of Hookipa Pharma Inc., reports the acquisition of restricted stock units (RSUs) that will vest over the next two years.

Summary

• On July 22, 2024, Mary Theresa Coelho, the EVP and CFO of Hookipa Pharma Inc., was granted 69,875 restricted stock units (RSUs).
• These RSUs represent a contingent right to receive one share of Hookipa Pharma Inc.'s common stock per RSU.
• The RSUs will vest in two equal installments on July 22, 2025, and July 22, 2026, contingent upon Ms. Coelho's continuous service with the company through those dates.
• Following this transaction, Ms. Coelho beneficially owns 69,875 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it incentivizes management. The sentiment is moderately positive.

Positives

• The grant of RSUs to a key executive like the CFO can be seen as an incentive to remain with the company and contribute to its long-term success.
• The vesting schedule aligns the executive's interests with those of the shareholders over a two-year period.

Future Outlook

The vesting of the RSUs is contingent upon the Reporting Person's continuous service through each vesting date.

Industry Context

Grants of restricted stock units are a common form of executive compensation in the pharmaceutical industry, used to align management's interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Executive compensation packages, including RSU grants, are common in the biopharmaceutical industry.
• Companies like Moderna and BioNTech also utilize equity-based compensation to incentivize their executives.
• The size of the RSU grant should be compared to industry benchmarks for similar roles and company size to assess its competitiveness.

Stakeholder Impact

• Shareholders may view the RSU grant as a positive incentive for the CFO to remain with the company and contribute to its success.
• Employees may see this as a sign of the company's commitment to rewarding its executives.

Key Dates